Awards/PROJECT GRANT (B)

$64,812,576

Department of Health and Human Services·National Institutes of Health

to WASHINGTON UNIVERSITY, THE

biotechactiveONGOING · MOD OF 2020 CONTRACT

WORK BEGAN2020-09-15·LATEST ACTION2026-05-05·SOURCEUSASPENDING·SOURCE IDASST_NON_R01AG068319_075

Award description

DIAN-TU: TAU NEXT GENERATION PREVENTION TRIAL

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds the DIAN-TU tau prevention trial, a clinical research study testing tau-targeting therapies to prevent Alzheimer's disease in at-risk populations.

Sub-sectors

nih-research-granttau-protein-researchalzheimers-prevention

Why this matters

Tau pathology is central to Alzheimer's; this large NIH investment targets a critical mechanism for disease prevention in preclinical stages.

Supply-chain signal

Drives demand for tau biomarker assays, imaging services, clinical trial infrastructure, and pharmaceutical development partnerships.

U.S.–China competition angle

U.S. leadership in Alzheimer's prevention research; China is also investing heavily in dementia research, making this a competitive scientific priority.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002356.

Period of performance

Start

2020-09-15

End

2027-05-31

Status

activein 379 days

Recipient

WASHINGTON UNIVERSITY, THE

UEI L6NFUM28LQM5

View full profile →

Other awards from this recipient

See all →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_R01AG068319_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.